Workington infected blood victim wants compensation paid quicker
He said risks from infected blood were too often ignored in the 1980s."The government and the NHS were aware the blood treatments blood transfusions, could be infected with hepatitis C and in some cases HIV," he said.Last June he was also diagnosed with bowel cancer, to which his other health issues had made him vulnerable.
"I was told once I had a liver transplant, because of the immune-suppressant medication I take to stop my body rejecting the liver, I'll be at high risk of other cancers," he said.The 58-year-old retired council officer said he was one of thousands frustrated by the wait for full compensation."You check your emails every day to see if you've got an email inviting you to start your claim," he said. "You just want it to be over. You just want to get that finished, put it to one side and just move on with your life."He warned victims would miss out on the help they needed."Time is running out for some people. Two people die every four days from the condition they've now got and it's very important they receive their compensation."
More than 30,000 people in the UK are believed to have been infected with HIV or hepatitis C from contaminated blood or blood products in the 1970s and 1980s and about 3,000 have since died.The Infected Blood Public Inquiry chaired by Sir Brian Langstaff reported in May 2024 the scandal stemmed from a "catalogue of failures" and victims had been let down.The Infected Blood Compensation Authority (IBCA) says 475 people have so far been asked to start their compensation claim and 137 people have received a compensation offer."Our priority continues to be paying as many people as soon as possible. We are building a claim service and delivering compensation at the same time, to ensure we make payments as quickly as we can," an IBCA spokesman said. "With more dedicated claim managers in place, we are opening our service to more and more eligible people every week."A government spokesman said: "We have paid over £44m so far in compensation, over £1bn in interim payments, and set aside £11.8bn to compensate victims."While no amount of compensation will make up for the suffering people have endured, we are committed to delivering compensation as swiftly as possible."
Follow BBC Cumbria on X, Facebook, Nextdoor and Instagram.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Metro
an hour ago
- Metro
I'm proof 'Ozempic penis' exists — weight loss jabs gave me a huge boost in bed
Standing in front of the mirror, James* admired his new physique. Gone was the middle-aged spread and the gut that had been expanding rapidly since Christmas. Now, he was seeing muscles he'd never noticed before and looking at least 10 years younger. But that wasn't the best bit of his transformation. As he stood stark naked looking at his reflection, James couldn't help but notice that his penis also looked bigger than usual — and it was all down to 'miracle' weight loss drug Wegovy. The 55-year-old tells Metro: 'I'm not one to jump on celebrity fads, but I needed a little bit of an extra push. Dieting is the most painful, boring thing in the world and I'd heard a lot about Ozempic, so I did a lot of research and decided to give it a go. 'If it's good enough for Sharon Osbourne, it's good enough for me.' A semi-professional sportsman of two decades, James stepped back from competing last year, and alongside the fact he no longer had fitness targets helping him stay in shape, he found himself eating – and drinking – out of boredom. Wegovy, a brand name for semaglutide, is a GLP-1 inhibitor medication that targets the parts of the brain that regulate appetite and promotes the release of insulin when blood sugar levels are high. This makes people feel fuller, reducing hunger levels and cravings for high-fat foods. Alongside Mounjaro and Saxenda, it's one of three GLP-1 drugs prescribed by the NHS specifically for weight loss (whereas Ozempic – which uses the same active ingredient as Wegovy – is only approved for the treatment of type 2 diabetes) and is also available to purchase privately through specialist pharmacies. According to the UK Medicines and Healthcare products Regulatory Agency (MHRA), it can help reduce the risk of heart and circulatory disease in people living with excess weight. Wegovy is self-administered weekly with an injector pen, into the upper arms, stomach, thighs or buttocks. It's not a magic cure though. Patients still need to change their diet and reduce the amount of calories eaten to see effects, and regular exercise is also recommended. Additionally, there is evidence of weight regain when people stop using Wegovy. Common side effects of semaglutide include sickness, diarrhoea or constipation, headaches, tiredness, heartburn and bloating, while rarer problems can include gallbladder disease, inflammation of the pancreas, an increased heart rate and kidney issues. Although he was still exercising daily – clocking up an impressive 1,000km every month from cycling alone – when he stepped on the scales after a particularly indulgent Christmas, he decided things needed to change. So, six months ago, James started taking Wegovy. 'I think it's a miracle drug, to be honest,' he says. Getting rid of the dangerous visceral fat around his organs was the primary motivation for changing his lifestyle, but James admits: 'Sure, I wanted to look a little better too.' It was easy to get hold of Wegovy, which is a brand name for semaglutide and works in a similar way to Ozempic (though the latter isn't approved solely for weight loss in the UK, where it's specifically prescribed for the management blood sugar in type 2 diabetes patients). After putting his details into an online pharmacy – James admits he 'lied' on the application form to make sure he qualified – a fancy package of injectables arrived in the post. Describing the process of giving himself a jab in the stomach each week, James says: 'It doesn't hurt at all – you don't even feel it.' He began to feel the effects of the drug almost straight away though, becoming full after less food and having fewer cravings. At £160 to £260 (depending on the dose) per month, it's not cheap, but James reckons he's actually saving money overall. 'My weekly shop went down by £40 or £50 easily, and that's not including wine and Deliveroos which I spent about £80 to £100 a week on,' James explains. 'I've also saved a lot on toilet paper – I only go once a day now.' Since his first injection in February, the tech business owner claims he has lost 20% of his body weight. It's not just about dropping the kilos though, as James's blood pressure and visceral fat are both now back within a healthy range – and he's even sleeping better and not snoring. 'My body is in as good a condition as it's ever been,' he continues. 'I've got muscles in my forearm I never knew were there, I've lost fat and my muscles have come out. And my thighs look ridiculous.' Some men have claimed that taking GLP-1 injections hasn't just helped them lose inches from their waist, but has also added inches to their manhood — and even improved their performance in bed. The phenomenon, which has been dubbed 'Ozempic penis' on forums like Reddit, may be due to reduced fat around the pubic region which can make the penis appear larger. Dr Nidhi Kansal, an internal medicine physician at Northwestern Medicine in Chicago, tells Daily Mail these welcome side effects may also be caused by increased testosterone levels as a result of weight loss. Obesity in men has been linked to low testosterone, which can make you feel tired, lower your sex drive and impact erection quality, potentially making the penis look smaller. Losing weight (through medication or otherwise) can naturally boost the hormone, with a recent Endocrine Society report revealing a 20% rise in men being treated for obesity with GLP-1 medication. His confidence has been boosted too; a far cry from 'hibernating' at home and feeling self-conscious about his 'gut'. James (who is single and says he's 'blessed' to have never been married), adds: 'I look in the mirror and think, 'F*** me, I look good' these days.' Others have been equally complimentary about the newfound spring in his step too, and his exes remarking 'wow' when they see him now is a welcome consequence. Some people find their sex drive drops on semaglutide, as it can decrease the amount of dopamine (the pleasure neurotransmitter) released by more than just eating. Not for James, though, who says he's having 'better sex' as a result of the drug. 'If you have an impulsive drive for sex, it would affect that,' he explains. 'But I have a normal sexual appetite, so actually it's made me enjoy sex more because I'm not as self-conscious of my body and I've got more energy.' Apparently, Wegovy has also made an impact down below, and any fears people might have about it causing penis shrinkage are unfounded. 'If anything, my penis looks bigger, because you lose body fat around it and your overall mass gets smaller,' James says with a smile. 'It's like when you shave your bush and it makes it look bigger.' Nonetheless, he doesn't feel it's made him more attractive to women, as he believes they 'aren't interested in men's bodies.' 'They're interested in cars and money,' says James. 'The moral of the story is, you can be fat as long as you've got a big wallet and a nice car. You'll still attract women.' While he has managed to avoid the vast majority of potential side effects these weight loss drugs can cause, from diarrhoea to dizziness, James admits there have been some other downsides. His transformation meant he needed to buy a whole new wardrobe, and he finds he gets much colder now, needing to wear thermals and multiple layers in June. And while James did notice his face becoming more sallow as he lost weight, he leaned into the image overhaul and decided to have fillers, which 'made a massive difference' to counteract the telltale 'Ozempic face'. Wegovy impacts your appetite, but you won't go off your food altogether. James says: 'I eat normally – low GI cereal with fruit for breakfast and a protein shake for lunch; I gave up my lunchtime bagel. Dinner is normally a salad of some type with chicken, maybe pitta and hummus. 'On Sunday I had a sausage and a burger, as well as a bottle of wine with friends. Before I would have thought, 'that burger was great', and have a second one. I don't do that now.' You'll likely want fewer fatty foods while taking Wegovy, but it's important to balance eating in a caloric deficit with ensuring you get the nutrients you need. Like many users, James tends not to tell people he's taking Wegovy, as some consider it 'cheating' – a viewpoint he refutes. Instead, he thinks it should be made universally available for free or cheap. 'I think it's a tool, much like you can use anything as a tool,' he says. 'It's impossible to succeed without training and working out and eating more healthily. Yes, I perhaps wanted a bit of a quick fix. But it hasn't been a quick fix.' More Trending After reaching a plateau, James is now looking to come off the medication. But is he worried he'll revert back to his old ways once he does? 'I don't know,' he admits. 'I don't want to be on it for the rest of my life, but it was almost impossible for me to lose the weight I wanted to lose without it. It's like a little guardian angel on your shoulder saying 'Don't eat that!'.' View More » This article was first published on August 8, 2024. Do you have a story to share? Get in touch by emailing MetroLifestyleTeam@ MORE: Coronation Street star Kimberly Hart-Simpson receives support as she shares diagnosis MORE: Chloe Ayling: 'The email that made me realise why people doubted my kidnapping' MORE: Buried alive: How 33 men survived being trapped underground for 69 days Your free newsletter guide to the best London has on offer, from drinks deals to restaurant reviews.
Daily Record
an hour ago
- Daily Record
UK households told to close windows for next 4 weeks to deter one terrifying visitor
It's the time of year when an unwanted guest may be looking to get into your home Spiders in the house are part and parcel of the summer months. But August is when false widows, considered the most venomous arachnid in the UK, are on the march and experts have urged householders to act. The huge spiders, which can bite and dish out pain comparable to a wasp sting, are in their annual mating season march indoors as they search for warm corners. And homeowners have been urged to close all windows day and night to keep them out. Although they will only bite if they feel threatened, it can result in painful swelling at the site. In more serious cases, some people can experience an allergic reaction to their venom. The NHS advises calling 999 and asking for an ambulance if you experience any of the following symptoms from a bite (from any spider or insect): Lips, mouth, throat or tongue suddenly become swollen Wheezing or difficulty breathing Skin, tongue or lips turn blue, grey or pale You suddenly become very confused, drowsy or dizzy Fainting A child is limp, floppy or not responding like they normally do Three species of false widow spiders are very similar, according to The Wildlife Trusts, and all can be found around the home at this time of year. There's the Rabbit hutch spider (Steatoda bipunctata), the Cupboard spider (Steatoda grossa) and the Noble false widow spider (Steatoda nobilis). The noble false widow is the largest of the three, with females growing up to 14mm in body length (10mm for males). Leading arachnologist Dr Tom Elwood has some tips to keeping the spiders, which belong to the same family as the deadly Black Widow spider, away, reports The Express. Dr Elwood said: 'August is when male spiders become active. They're searching for a mate and they'll wander through open windows, up walls, into bathtubs — anywhere they can." Dr Elwood says it's not only open windows that draw spiders in — it's the dust and debris found on many window sills and frames. "Spiders are drawn to dust, insect remains and debris on window frames," he explains. "Webs cling better to rough or grimy surfaces. That's why cleaning your windows is just as important as keeping them shut." These spiders are often reported on floors, along skirting boards and up walls. 'Spiders are drawn to dust, insect remains and debris on window frames,' he explains. 'Webs cling better to rough or grimy surfaces. That's why cleaning your windows is just as important as keeping them shut.' These spiders are often reported on floors, along skirting boards and up walls. How to keep False Widows out: Dr Elwood says: 'Do the right things now, and you won't be waking up to spiders crawling across your bedroom floor.'
Telegraph
an hour ago
- Telegraph
‘NHS cut funding to my 98-year-old grandmother because she didn't die on time'
The NHS has been accused of leaving a 98-year-old to 'die without dignity' after cutting vital care funding with just days' notice. Pearl Henderson, a grandmother from Bradford with end-stage dementia, was fast-tracked on to NHS Continuing Healthcare (CHC) in 2023. Under this valuable scheme, the NHS pays for care if a patient has serious long-term health problems. But on Friday, the NHS West Yorkshire Integrated Care Board (ICB) axed Ms Henderson's funding despite her extremely weak condition requiring 13 hours of care per day. It comes as experts warn of a 'troubling' rise in NHS CHC patients getting their funding axed in end of life care, particularly in cases involving the Fast Track Pathway due to widespread budget cuts. The decision means the local authority will now foot the bill for Ms Henderson's care, but they can only afford to pay for 2.5 hours worth of visits every 24 hours. Ms Henderson's family fear the sharp drop in care hours will cause the 98-year-old's condition to rapidly deteriorate. 'They're bringing forward her death' Her granddaughter Kirstie Lumley, 36, from North Yorkshire, said: 'She's really frail, she probably weighs about four and a half stone now, she needs constant care, she has absolutely no mental cognition any more. 'We're not trying to extend her life at all, she's 98, but we're trying to get her to die with some kind of dignity. 'She's going to be sat for 21 hours a day alone, soiled. All they're doing is bringing forward her death, leaving her unsafe and unclean. The thought of it is heartbreaking.' Ms Lumley is concerned the ICB ended her grandmother's care package in order to cut costs. 'She was fast-tracked with dementia in 2023 and she's basically lived longer than expected. From their perspective, she hasn't died on time. She was expected to die within six weeks of leaving hospital.' Judith Cummins, MP for Bradford South, said her constituent's situation was 'deeply distressing'. She said: 'I have been in contact with the West Yorkshire ICB to seek an urgent review of Pearl's case, and I will continue to support Pearl, Kirstie, and their family on this matter. 'I will always fight to ensure that my constituents can live with dignity.' Extreme funding cuts A growing body of evidence suggests this is not an isolated incident but part of a concerning trend. Data obtained by The Telegraph shows a rise in the number of vulnerable patients stripped of critical funding by the NHS. Last year 1,600 individuals lost access to continuing healthcare following a review by the ICB, up from around 1,300 the year before, according to figures from 16 of England's 42 ICBs. These organisations are responsible for deciding who qualifies for CHC funding. Of the 16 ICBs that provided data in response to Freedom of Information requests, 12 had seen a year-on-year increase in funding withdrawals. In some cases, the number of withdrawals had more than doubled over time. For example, NHS Norfolk and Waveney ICB cut funding for 127 individuals last year – up from 72 the year before and just 23 in 2021-22. Similarly, NHS Greater Manchester ICB decided 191 individuals were no longer eligible for funding last year following an assessment – up from 185 the year before and just 107 in 2021-22. Meanwhile the NHS Suffolk and North East Essex ICB stopped paying for care for 62 individuals last year, compared to 15 in 2023-24 and fewer than five in 2021-22. Experts blamed the cuts on funding pressures. Jane Townson, of the Homecare Association, said: 'The driver is that NHS ICBs are required to reduce running costs by 50pc, so there is cost cutting all over the place.' This year, ICBs were asked to reduce budgets as part of the Government's major NHS reforms. But this has put more pressure on local councils – who must often step in to cover the cost of care. Almost three quarters of social care directors have seen an increase in the number of people requesting care from local authorities because they no longer qualify for NHS CHC following an assessment, according to a recent survey by the Association of Directors of Adult Social Services. James Urquhart-Burton, of Winston Solicitors, said he had noticed a 'troubling' rise in NHS CHC patients getting their funding axed, particularly in cases involving the Fast Track Pathway. Fast Track is intended for patients who may be approaching the end of their life. But Mr Urquhart-Burton said he had seen ICBs cutting Fast Track CHC funding 'within weeks' of granting it. He went on: 'These cases often involve individuals who are rapidly deteriorating and entering a terminal phase – precisely the circumstances Fast Track CHC is designed to support.' Ms Henderson, who first obtained funding under the Fast Track, requires regular visits throughout the day to feed and clean her and prevent her from accidentally harming herself, for example, by falling out of bed. She used to receive eight 30-minute visits plus a nine-hour night sit, totalling 13 hours of care every 24 hours. But the local authority can only stretch to four 30-minute visits per day and one 30-minute visit at night. Ms Lumley believes the NHS West Yorkshire ICB failed to follow the correct procedure when reassessing her grandmother's needs. Vulnerable patients pay the price ICBs use a complex set of criteria to assess health conditions. According to NHS guidelines, reviews should take place after three months, and at least every 12 months after that, to check if the care package remains appropriate. After that time period, the person may be fully reassessed. However, the guidelines state it is not appropriate to reassess a person given funding through the Fast Track who is rapidly deteriorating. Ms Lumley said there was no evidence a review took place before her grandmother was reassessed. In addition, an assessor told her the funding was going to be cut before they had even finished the assessment. 'When the CHC assessor came into the meeting, she said, 'I'm not here to make a decision, I'm just here to fact find.' And then before she'd even left the meeting she said, 'Look, usually we'd go away and discuss it but, I'll be really honest with you now, we're going to pull it.'' Mr Urquhart-Burton said he had seen more ICBs giving up on preliminary reviews. 'In many instances, these assessments are being arranged without a preliminary review of whether the care arrangements remain appropriate, as outlined in the National Framework for NHS Continuing Healthcare. 'This not only undermines the intent of Fast Track funding but also places undue pressure on families, who are often given very short notice and little support in navigating the process.' Ms Lumley said: 'We were so proud of the NHS, it stood out across the world. And now, you look at it and think: 'What happened?' 'My grandmother has paid tax all her life, and she's never claimed a penny. All the hundreds of thousands of pounds she's paid in tax throughout the years, and it doesn't give you the ability to die with dignity in the UK.' A spokesman for NHS West Yorkshire ICB said: 'We have a responsibility to ensure that continuing healthcare decisions are fair, transparent, and based on assessed need, in accordance with the National Framework for NHS continuing healthcare and NHS-funded nursing care. 'These assessments often involve people who are frail or have multiple needs, with families and carers providing considerable support. We appreciate that continuing healthcare decisions can be significant for individuals and families, especially in complex and sensitive circumstances, with outcomes potentially causing some disappointment and distress. 'While we cannot comment on individual cases, we can confirm that we are reviewing the matters raised here in line with our policy and complaints process.' A spokesman for NHS England said: 'Eligibility for NHS continuing healthcare funding is determined on an individual basis by health and social care professionals in line with government guidance and regulation, to ensure there is a consistent approach across the country.' A spokesman for NHS Greater Manchester ICB said: 'While we've seen a rise in referrals and fast-track cases across Greater Manchester, which can lead to more reviews and occasional funding changes, all decisions are made using a nationally governed framework that ensures consistency, fairness, and transparency. 'Our priority remains to support individuals with compassion and ensure their care needs are fully met.'
